Staphylococcal toxic shock syndrome: Suspicion and prevention are keys to control

Postgraduate Medicine

Volumn 110, Issue 4, 2001, Pages 55-62

  Issa, Nicolas C ^a   Thompson, Rodney L ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; INTERLEUKIN 6; NAFCILLIN; OXACILLIN; RIFAMPICIN; STAPHYLOCOCCUS ENTEROTOXIN; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN;

ANTIBIOTIC THERAPY; BACTERIUM CULTURE; CLINICAL EXAMINATION; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DRUG CHOICE; HUMAN; IMMUNOPATHOGENESIS; PATHOPHYSIOLOGY; RISK FACTOR; STAPHYLOCOCCUS INFECTION; TOXIC SHOCK SYNDROME; TREATMENT PLANNING;

ALGORITHMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MENSTRUATION; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0034797660     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2001.10.1045     Document Type: Article

References (24)

1. Todd J, Fishaut M, Kapral F, et al. Toxic-shock syndrome associated with phage-group-1 staphylococci. Lancet 1978; 2 (8100): 1116 – 8
2. Schrock CG. Disease alert. (Letter) JAMA 1980; 243 (12): 1231
3. Centers for Disease Control. Follow-up on toxic-shock syndrome—United States. MMWR Morb Mortal Wkly Rep 1980; 29 (25): 297 – 9
4. Centers for Disease Control. Toxic-shock syndrome—Utah. MMWR Morb Mortal Wkly Rep 1980; 29 (41): 495 – 6
5. Davis JP, Chesney PJ, Wand PJ, et al. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 1980; 303 (25): 1429 – 35
6. Bonventre PF, Weckbach L, Harth G, et al. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin. Rev Infect Dis 1989; 11 (Suppl 1): S90 – 5
7. Osterholm MT, Davis JP, Gibson RW, et al. Tri-state toxic-shock syndrome study I; epidemiologic findings. J Infect Dis 1982; 145 (4): 431 – 40
8. Strausbaugh LJ. Toxic shock syndrome: Are you recognizing its changing presentations? Postgrad Med 1993; 94 (6): 107 – 18
9. Gaventa S, Reingold AL, Hightower AW, et al. Active surveillance for toxic shock syndrome in the United States, 1986. Rev Infect Dis 1989; 11 (Suppl 1): S28 – 34
10. Hajjeh RA, Reingold A, Weil A, et al. Toxic shock syndrome in the United States: surveillance update, 1979–1996. Emerg Infect Dis 1999; 5 (6): 807 – 10
11. Makida R, Hofer MF, Takase K, et al. Bacterial superantigens induce V beta-specific T cell receptor internalization. Mol Immunol 1996; 33 (10): 891 – 900
12. Herman A, Kappler JW, Marrack P, et al. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol 1991; 9: 745 – 72
13. Manders SM. Toxin-mediated streptococcal and staphylococcal disease. J Am Acad Dermatol 1998; 39 (3): 383 – 98
14. Bohach GA, Kreiswirth BN, Novick RP. Analysis of toxic shock syndrome isolates producing staphylococcal enterotoxins B and C1 with use of southern hybridization and immunologic assays. Rev Infect Dis 1989; 11 (Suppl 1): S75 – 81
15. Crass BA, Bergdoll MS. Toxin involvement in toxic shock syndrome. J Infect Dis 1986; 153 (5): 918 – 26
16. Schlievert PM. Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. (Letter) Lancet 1986; 1 (8490): 1149 – 50
17. Schlievert PM, Blomster DA. Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J Infect Dis 1983; 147 (2): 236 – 42
18. Kass EH, Schlievert PM, Parsonnet J, et al. Effect of magnesium on production of toxic-shock-syndrome toxin-1: a collaborative study. J Infect Dis 1988; 158 (1): 44 – 51
19. Arnow PM, Chou T, Weil D, et al. Spread of a toxic-shock syndrome-associated strain of Staphylococcus aureus and measurement of antibodies to staphylococcal enterotoxin F. J Infect Dis 1984; 149 (1): 103 – 7
20. Chesney PJ. Clinical aspects and spectrum of illness of toxic shock syndrome: overview. Rev Infect Dis 1989; 11 (Suppl 1): S1 – 7
21. Weston WL, Todd JK. Toxic-shock syndrome. J Am Acad Dermatol 1981; 4 (4): 478 – 80
22. Parsonnet J, Modern PA, Giacobbe K. Effect of subinhibitory concentrations of antibiotics on production of toxic shock syndrome toxin-1 (TSST-1). (Abstr) Program and abstracts of the 32nd meeting of the Infectious Disease Society of America, Orlando, Fla, Oct 7–9, 1994: 6A
23. Tofte RW, Williams DN. Toxic shock syndrome: clinical and laboratory features in 15 patients. Ann Intern Med 1981; 94 (2): 149 – 56
24. Shands KN, Schmid GP, Dan BB, et al. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med 1980; 303 (25): 1436 – 42